Animi-3 with Vitamin D Interactions
There are 76 drugs known to interact with Animi-3 with Vitamin D (omega-3 polyunsaturated fatty acids), along with 2 disease interactions. Of the total drug interactions, 76 are moderate.
- View all 76 medications that may interact with Animi-3 with Vitamin D
- View Animi-3 with Vitamin D disease interactions (2)
Most frequently checked interactions
View interaction reports for Animi-3 with Vitamin D (omega-3 polyunsaturated fatty acids) and the medicines listed below.
- acetaminophen / butalbital / caffeine
- Adderall (amphetamine / dextroamphetamine)
- Adipex-P (phentermine)
- Advicor (lovastatin / niacin)
- albuterol / ipratropium
- Aldactone (spironolactone)
- Alli (orlistat)
- allopurinol
- alprazolam
- atenolol
- cyclobenzaprine
- Cymbalta (duloxetine)
- doxycycline
- fenofibrate
- fluoxetine
- gabapentin
- hydrochlorothiazide
- lisinopril
- lovastatin
- magnesium oxide
- metformin
- Metoprolol Succinate ER (metoprolol)
- mupirocin topical
- Nexium (esomeprazole)
- pantoprazole
- phentermine / topiramate
- pravastatin
- Prozac (fluoxetine)
- simvastatin
- trazodone
Animi-3 with Vitamin D disease interactions
There are 2 disease interactions with Animi-3 with Vitamin D (omega-3 polyunsaturated fatty acids) which include:
Report options
QR code containing a link to this page
More about Animi-3 with Vitamin D (omega-3 polyunsaturated fatty acids)
- Animi-3 with Vitamin D consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.